Status:
COMPLETED
Dyslipidemia Management in Chinese Post Stroke Patients
Lead Sponsor:
AstraZeneca
Conditions:
Brain Ischemia,Stoke
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to provide current and reliable data of dyslipidimia management together with control situation of blood pressure and glucose for post-stroke patients within 6-12 months f...
Detailed Description
This is a multicentre, cross-sectional, observational study, aiming to investigate the prevalence and control situation of dyslipidimia in China post ischemic stroke patients within 6-12 months from a...
Eligibility Criteria
Inclusion
- Male or female with age ≥ 18 years
- Post ischemic stroke patients within 6-12 months from attack
- written informed consent is provided to participant in the study
Exclusion
- Significant medical or psychological condition that make patients can not finish the questionnaire independently or with the aids of his/her legal representatives
- The patient is or will be in another clinical study
- Previous enrolment in the present study
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2014
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT01897883
Start Date
July 1 2013
End Date
August 1 2014
Last Update
July 30 2015
Active Locations (26)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Beijing, Beijing Municipality, China
2
Research Site
Guangzhou, Guangdong, China
3
Research Site
Shenzhen, Guangdong, China
4
Research Site
Haerbin, Heilongjiang, China